Jason P. Rhodes, an insider at Dyne Therapeutics, Inc. (DYN), sold 253,039 shares of the company's stock on July 8, 2026. The transactions occurred at an average price of $22.79 per share, resulting in a total value of approximately $5.77 million.
This sale follows a series of other transactions by Mr. Rhodes on July 7, 2026, which involved the sale of over 235,000 shares across multiple trades totaling more than $5.3 million.
Insider sales can be driven by various factors, including portfolio diversification, tax obligations, or pre-arranged trading plans, and do not necessarily indicate a negative outlook on the company's future performance.